Who invested in BlissBio?
BlissBio's investors include Cormorant Asset Management, Oriental Fortune Capital and Sherpa Healthcare Partners.
Who invested in BlissBio
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$15Mraised across 1 round since 2023, from 1 source
- Latest round
- Series B, $15MJan 2023
- Investors
- 3
The rounds
- Jan 2023Series B$15M
Source recorded
Everyone who backed them
Sherpa Healthcare PartnersVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about BlissBio
How much has BlissBio raised?
BlissBio has raised $15M across 1 round since 2023.
When did BlissBio last raise?
BlissBio's most recent round was a Series B of $15M in Jan 2023.
What was BlissBio's biggest round?
Its most recent round, $15M in Jan 2023, is also its largest on record.
Who backed BlissBio first?
BlissBio's first round on record, in Jan 2023, was backed by Cormorant Asset Management, Oriental Fortune Capital and Sherpa Healthcare Partners.
What stage is BlissBio at?
BlissBio's latest named round is a Series B, in Jan 2023.
Companies like BlissBio
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.